Rotavirus G9P[4] in 3 countries in Latin America, 2009-2010.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 3739533)

Published in Emerg Infect Dis on August 01, 2013

Authors

Osbourne Quaye, Sharla McDonald, Mathew D Esona, Freda C Lyde, Slavica Mijatovic-Rustempasic, Sunando Roy, Dina J Castro Banegas, Yolanda Mencos Quiñonez, Blanca L Chinchilla, Fabián Gómez Santiago, Herlinda García Lozano, Gloria Rey-Benito, Lúcia H de Oliveira, Jon R Gentsch, Michael D Bowen

Articles by these authors

Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87

Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med (2006) 3.38

Rotavirus vaccines: current prospects and future challenges. Lancet (2006) 2.97

Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis (2004) 2.88

Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77

Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.23

Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis (2009) 2.12

Real-world impact of rotavirus vaccination. Pediatr Infect Dis J (2011) 1.89

Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis (2012) 1.86

United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J (2011) 1.83

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J (2011) 1.63

Detection of smallpox virus DNA by LightCycler PCR. J Clin Microbiol (2002) 1.62

First report from the Asian Rotavirus Surveillance Network. Emerg Infect Dis (2004) 1.60

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics (2010) 1.59

Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics (2008) 1.58

Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine (2012) 1.57

The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis (2002) 1.53

Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis (2005) 1.52

Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis (2009) 1.49

Evaluation of five commercial nucleic acid extraction kits for their ability to inactivate Bacillus anthracis spores and comparison of DNA yields from spores and spiked environmental samples. J Microbiol Methods (2008) 1.41

Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J (2009) 1.36

Global impact of rotavirus vaccines. Expert Rev Vaccines (2010) 1.34

Diversity of rotavirus strains among children with acute diarrhea in China: 1998-2000 surveillance study. J Clin Microbiol (2002) 1.29

Detection of pathogenic Vibrio parahaemolyticus in oyster enrichments by real time PCR. J Microbiol Methods (2003) 1.28

Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics (2011) 1.26

New oligonucleotide primers for P-typing of rotavirus strains: Strategies for typing previously untypeable strains. J Clin Virol (2008) 1.23

Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis (2013) 1.23

Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics (2010) 1.23

Natural nidality in Bolivian hemorrhagic fever and the systematics of the reservoir species. Infect Genet Evol (2002) 1.23

Changing patterns of rotavirus genotypes in ghana: emergence of human rotavirus G9 as a major cause of diarrhea in children. J Clin Microbiol (2003) 1.23

Use of a real time PCR assay for detection of the ctxA gene of Vibrio cholerae in an environmental survey of Mobile Bay. J Microbiol Methods (2006) 1.19

Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine (2008) 1.17

Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J (2010) 1.15

Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine (2010) 1.14

Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis (2005) 1.13

Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics (2013) 1.13

Outbreaks of adult gastroenteritis traced to a single genotype of rotavirus. J Infect Dis (2002) 1.11

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality. Expert Rev Vaccines (2012) 1.10

The pathology of rotavirus-associated deaths, using new molecular diagnostics. Clin Infect Dis (2003) 1.10

Comparison of commercial systems for extraction of nucleic acids from DNA/RNA respiratory pathogens. J Virol Methods (2010) 1.07

G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J Infect Dis (2009) 1.07

Update on rotavirus vaccines. Pediatr Infect Dis J (2005) 1.06

Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J Virol (2004) 1.06

Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine (2006) 1.05

Rotavirus disease and its prevention. Curr Opin Gastroenterol (2005) 1.05

Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J Virol (2007) 1.05

Reassortant group A rotavirus from straw-colored fruit bat (Eidolon helvum). Emerg Infect Dis (2010) 1.04

Protein kinase R mediates intestinal epithelial gene remodeling in response to double-stranded RNA and live rotavirus. J Immunol (2005) 1.02

The expanding diversity of rotaviruses. Lancet (2002) 1.01

Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine (2012) 1.00

Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine (2011) 0.99

Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ (2013) 0.97

One year survey of human rotavirus strains suggests the emergence of genotype G12 in Cameroon. J Med Virol (2013) 0.97

Development of a microtiter plate hybridization-based PCR-enzyme-linked immunosorbent assay for identification of clinically relevant human group A rotavirus G and P genotypes. J Clin Microbiol (2007) 0.97

Sensitive and specific quantitative detection of rotavirus A by one-step real-time reverse transcription-PCR assay without antecedent double-stranded-RNA denaturation. J Clin Microbiol (2013) 0.97

Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics (2011) 0.96

Emergence of serotype G12 rotaviruses, Hungary. Emerg Infect Dis (2007) 0.96

Comparison of Premier™ Rotaclone®, ProSpecT™, and RIDASCREEN® rotavirus enzyme immunoassay kits for detection of rotavirus antigen in stool specimens. J Clin Virol (2013) 0.96

Genetic diversity and zoonotic potential of human rotavirus strains, 2003-2006, Hungary. J Med Virol (2009) 0.96

Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis (2012) 0.95

Molecular characterization of human rotavirus vaccine strain CDC-9 during sequential passages in Vero cells. Hum Vaccin (2010) 0.94

Diverse origin of P[19] rotaviruses in children with acute diarrhea in Taiwan: Detection of novel lineages of the G3, G5, and G9 VP7 genes. J Med Virol (2011) 0.93

Epidemiology of rotavirus gastroenteritis among children <5 years of age in Morocco during 1 year of sentinel hospital surveillance, June 2006-May 2007. J Infect Dis (2009) 0.93

Comparison of 2 assays for diagnosing rotavirus and evaluating vaccine effectiveness in children with gastroenteritis. Emerg Infect Dis (2013) 0.93

Evaluation of automated and manual commercial DNA extraction methods for recovery of Brucella DNA from suspensions and spiked swabs. J Clin Microbiol (2009) 0.92

Rapid identification and discrimination of Brucella isolates by use of real-time PCR and high-resolution melt analysis. J Clin Microbiol (2010) 0.92

Rotavirus G and P types circulating in the eastern region of Kenya: predominance of G9 and emergence of G12 genotypes. Pediatr Infect Dis J (2014) 0.92

Molecular epidemiology of group A rotavirus in Buenos Aires, Argentina 2004-2007: reemergence of G2P[4] and emergence of G9P[8] strains. J Med Virol (2010) 0.92

Genetic diversity among Bolivian arenaviruses. Virus Res (2008) 0.92

Comparative evaluation of commercially available manual and automated nucleic acid extraction methods for rotavirus RNA detection in stools. J Virol Methods (2013) 0.91

Real-time PCR quantification of Vibrio parahaemolyticus in oysters using an alternative matrix. J Food Prot (2004) 0.91

Zoonotic bovine rotavirus strain in a diarrheic child, Nicaragua. J Clin Virol (2009) 0.90

First reports of human rotavirus G8P[4] gastroenteritis in the United States. J Clin Microbiol (2011) 0.90

Dominating prevalence of P[8],G1 and P[8],G9 rotavirus strains among children admitted to hospital between 2000 and 2003 in Budapest, Hungary. J Med Virol (2005) 0.90